Silver Book Fact

A year-long study of patients with congestive heart failure found that increased use of medicines increased pharmaceutical costs by 60%; however, hospital costs declined by 78%, producing a net savings of $9.3 million. The ability of patients to perform activities of daily living went up 15% and the death rate dropped from an expected 25% to 10%.

Managed Healthcare. Provide Education About Congestive Heart Failure and Pump Up Your Savings; Mar-1998:42-4

Reference

Title
Provide Education About Congestive Heart Failure and Pump Up Your Savings
Publication Date
Mar-1998
Authors
Managed Healthcare
Volume & Issue
Volume 8, Issue 4
Pages
42-4

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • New approaches are under development to reduce ischemic stroke damage and other damage occuring because of stroke.  
  • Antihypertensive Medicines Have Prevented Deaths and Hospitalizations: Study quantified impact of high blood pressure drugs on the U.S. population 1999-2000  
  • TAVR Procedures 2011 – 2015
    From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states.  
  • Treating acute stroke with drugs that minimize cell death could result in a median decrease in disability of 30%. Treatment with stem cell transplants could result in a median decrease…